More and more of the new OSD drugs comprise of highly active components, where just milligrams of API are required for one daily medical dose. Thus, the pharmaceutical industry is facing increasing demand from regulatory authorities to achieve lower limits with regards to cross contamination. On the other side, rising HSE requirements come up, in order to avoid negative health effects to the personnel producing those medicines.
PDE, OEL, or OEB are the major key words related to that topic. How much containment is actually required? How do I work with products with an OEL less than 1 μg/m3? How clean is clean? How do I achieve the required cleanliness of my equipment? What is the regulatory authorities view on containment and highly active API?
Increase you Containment Competence with the TTC Workshop "COMPETENT CONTAINMENT"
Feb 27 - March 01 2018 in Binzen, Germany
www.ttc-binzen.de
